FDA’s Office Of Regulatory Affairs Loses Two Top Officials, Including Chief
This article was originally published in The Gray Sheet
Executive Summary
The face of FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing the agency's inspections and enforcement activity